PRTA 8-K: SEC filing

Prothena

Filed with the SEC on · accession 0001559053-26-000030

PRTA filed a 8-K (current report) with the SEC on Nov 5, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -6.0% by the first close after the filing.

Summary of the filing

Prothena reported Q3 2026 financial results with a net loss of $16.5 million, an improvement from a $36.5 million loss in Q3 2025, and highlighted progress across its partnered clinical programs including prasinezumab, coramitug, and moponetug.

Key details

Net loss for Q3 2026$16.5M
Net loss for first nine months of 2026$2.4M
Net loss for Q3 2025$36.5M
Net loss for first nine months of 2025$222.5M
Net cash used in operating and investing activities in Q3 2026$12.0M
Net cash used in operating and investing activities for first nine months of 2026$8.9M
Cash and restricted cash position at quarter-end$272.2M
Upfront, milestone and equity payments generated from partnered programs$650.0M
Potential additional milestone payments from partnered programs$2.3B
IssuerProthena Corporation plc
Partner for prasinezumabRoche
Partner for coramitugNovo Nordisk
Partner for moponetugBristol Myers Squibb
President and chief executive officerGene Kinney

How PRTA stock reacted

Close before

$8.39

Nov 4, 2026

First close after

-5.96%

$7.89

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for PRTA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PRTA?

Click here

Frequently asked questions

What did PRTA file with the SEC on Nov 5, 2026?

PRTA filed a 8-K (SEC filing). Prothena reported Q3 2026 financial results with a net loss of $16.5 million, an improvement from a $36.5 million loss in Q3 2025, and highlighted progress across its partnered clinical programs including prasinezumab, coramitug, and moponetug.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did PRTA stock react to this filing?

PRTA closed at $8.39 before the filing and $7.89 on Nov 5, 2026 (-5.96%).

Other PRTA SEC filings

Get alerts when PRTA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days